ECSP045053A - PHARMACEUTICAL COMPOSITIONS THAT INCLUDE MYCOPHENOLIC ACID OR MYCOPHENOLATE SALT - Google Patents

PHARMACEUTICAL COMPOSITIONS THAT INCLUDE MYCOPHENOLIC ACID OR MYCOPHENOLATE SALT

Info

Publication number
ECSP045053A
ECSP045053A ECSP045053A ECSP045053A EC SP045053 A ECSP045053 A EC SP045053A EC SP045053 A ECSP045053 A EC SP045053A EC SP045053 A ECSP045053 A EC SP045053A
Authority
EC
Ecuador
Prior art keywords
mycophenolic acid
pharmaceutical compositions
mycophenolate salt
include mycophenolic
mycophenolate
Prior art date
Application number
Other languages
Spanish (es)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40435091&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP045053(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Priority to ECSP045053 priority Critical patent/ECSP045053A/en
Publication of ECSP045053A publication Critical patent/ECSP045053A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención proporciona una forma de dosis sólida, por ejemplo, una tableta, que comprende ácido micofenólico o una sal de micofenolato y un procedimiento para su producción.The invention provides a solid dosage form, for example, a tablet, comprising mycophenolic acid or a mycophenolate salt and a method for its production.

ECSP045053 2004-04-08 2004-04-08 PHARMACEUTICAL COMPOSITIONS THAT INCLUDE MYCOPHENOLIC ACID OR MYCOPHENOLATE SALT ECSP045053A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP045053 ECSP045053A (en) 2004-04-08 2004-04-08 PHARMACEUTICAL COMPOSITIONS THAT INCLUDE MYCOPHENOLIC ACID OR MYCOPHENOLATE SALT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP045053 ECSP045053A (en) 2004-04-08 2004-04-08 PHARMACEUTICAL COMPOSITIONS THAT INCLUDE MYCOPHENOLIC ACID OR MYCOPHENOLATE SALT

Publications (1)

Publication Number Publication Date
ECSP045053A true ECSP045053A (en) 2004-05-28

Family

ID=40435091

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP045053 ECSP045053A (en) 2004-04-08 2004-04-08 PHARMACEUTICAL COMPOSITIONS THAT INCLUDE MYCOPHENOLIC ACID OR MYCOPHENOLATE SALT

Country Status (1)

Country Link
EC (1) ECSP045053A (en)

Similar Documents

Publication Publication Date Title
ECSP024341A (en) PHARMACEUTICAL COMPOSITIONS
UY30712A1 (en) NEW DERIVATIVES OF 1, 4-BENZOTIEPINA-1, 1-DIOXIDE REPLACED WITH FLUOR, METHOD FOR PREPARATION, PHARMACEUTICAL PRODUCTS THAT UNDERSTAND THESE COMPOUNDS AND THEIR USE.
UY30711A1 (en) NEW DERIVATIVES OF 1,4-BENZOTIEPINA-1, 1-CIOXIDE, METHOD FOR PREPARATION, PHARMACEUTICAL PRODUCTS THAT INCLUDE THESE COMPOUNDS AND THEIR USE.-
ECSP11011307A (en) TABLETS FOR COMBINATION THERAPY
DOP2017000306A (en) PHARMACEUTICAL FORMULATIONS CONTAINING TENOFOVIR AND EMTRICITABINE
CL2007003797A1 (en) COMPOUNDS DERIVED FROM PIRROLO PIRIDINA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE FOR THE TREATMENT OF THE DISEASE OF ALZHEIMER, PARKINSON, CANCER, AMONG OTHER ILLNESSES.
FR2883179B1 (en) COATED TABLET
BRPI0520669A2 (en) pharmaceutical dosage that reduces the effect of food found for atorvastatin administration
BRPI0814957A2 (en) COMPOUND, PRODUCT, PHARMACEUTICAL AGENT, METHOD FOR PROPHYLAXY OR TREATMENT OF A DISEASE, DISORDER OR CONDITION, AND USE OF THE COMPOUND.
UA89220C2 (en) METHOD OF TREATMENT OF HIV / AIDS BY INJURY WITHOUT FOOD OR UNDER CONDITIONS OF STORAGE OF SOLID PHARMACEUTICAL DOSAGE INHIBITOR INHIBITOR
IT1395035B1 (en) DOUBLE LINE MACHINE AND METHOD FOR THE CONSTRUCTION OF COMPOUND FILTERS FOR CIGARETTES, CIGARS OR THE LIKE.
CO6470841A2 (en) SOLID PREPARATION THAT PRESENTS PROPERTY OF IMPROVED DISSOLUTION OF A MEDICINAL PRODUCT FROM THE SAME
BRPI0719880A2 (en) PHARMACEUTICAL SOLID DOSAGE FORM FOR ORAL ADMINISTRATION AND METHOD FOR PREPARING THE SAME.
BR112012003280A2 (en) pharmaceutical composition for oral administration, method for treating a disease, use of the compound, and, compound.
BRPI0717369A2 (en) COMPOUND, MEDICINAL PRODUCT, PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THE COMPOUND.
EA201000039A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING SOLIFENACIN OR ITS PHARMACEUTICALLY ADAPTABLE SALT
PA8781501A1 (en) FORMATION OF PASSIREOTIDE
PL1845957T3 (en) Method for obtaining an extract of a drug containing hydroxystilbene
MX2010003591A (en) Mechanical protective layer for solid dosage forms.
TNSN07453A1 (en) Combination of pyrimidylaminobenzamide compounds and imatinib for treating or preventing proliferative diseases
EA200501221A1 (en) PHARMACEUTICAL COMPOSITION OF ALEDRONIC ACID, ITS SALTS OR COMPLEX AIRS AND METHOD FOR ITS PREPARATION
BRPI0516464B8 (en) method for preparing a pharmaceutical product
ECSP045053A (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE MYCOPHENOLIC ACID OR MYCOPHENOLATE SALT
MX385513B (en) PHARMACEUTICAL COMPOSITIONS INCLUDING SAFINAMIDE.
TW200503759A (en) Tablets comprising flavourings and/or aromatizing substances